心力衰竭(HF)为终末期慢病之一,并发症及死亡风险均高。临床上治疗HF在于改善其相关症状、降低死亡风险和防治其他心血管事件风险等。然而既往关于使用血管紧张素受体脑啡肽酶抑制剂与依那普利对HF继后恶化进展风险间作用对照研究罕见,现就此进行相关大样本对照分析。受试对象为8 399例HF患者,均为左室射血分数降低型HF,并均系出院后存活者。均在剔除曾使用过血管紧张素转 Heart failure (HF) is one of the end-stage chronic diseases with high risk of complications and death. The clinical treatment of HF is to improve its related symptoms, reduce the risk of death and prevent other cardiovascular events. However, previous studies comparing the effects of angiotensin receptor enkephalinase inhibitors and enalapril on the risk of subsequent progression of HF have been rare, and relevant large sample controls are now being analyzed. Subjects were 8 399 HF patients with reduced left ventricular ejection fraction (HF) and were all survived after discharge. Are removed in the past have used angiotensin transfer